DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bismuth subcitrate
Bismuth subcitrate
Combination Therapy for Peptic Ulcer Treatment
The Toronto Consensus for the Treatment of Helicobacter Pylori Infection in Adults Carlo A
Levofloxacin, Metronidazole, and Lansoprazole Triple Therapy Compared to Quadruple Therapy As a Second-Line Treatment of Helicobacter Pylori Infection in Korea
OMECLAMOX-PAK (Omeprazole, Clarithromycin, and Amoxicillin) PREVPAC (Lansoprazole, Clarithromycin, and Amoxicillin) PYLERA (Bism
Australian Statistics on Medicines 1997 Commonwealth Department of Health and Family Services
Bismuth Subcitrate
H. Pylori Infection Products
Stability of Metronidazole, Tetracycline Hcl and Famotidine Alone and in Combination
Bismuth Salts for Gastrointestinal Issues: a Review of the Clinical Effectiveness and Guidelines DATE
Furazolidone, Co-Amoxiclav, Colloidal Bismuth Subcitrate, and Esomeprazole for Patients Who Failed to Eradicate Helicobacter
H. Pylori Treatment Therapeutic Class Review (TCR) January 30, 2018
Prevpac Pylera Omeclamox Talicia March 2020 Annual Review
PYLERA™ Capsules
00745 Helidac (Bismuth Subsalicylate, Metronidazole, Tetracycline)
Bismuth-Based Triple Therapy with Bismuth Subcitrate, Metronidazole and Tetracycline in the Eradication of Helicobacter Pylori
Bismuth Subsalicylate Inthe Treatment of H2 Blocker Resistant Duodenal Ulcers: Role of Helicobacter Pylori
Institution/Department︰Kaohsiung Veterans General Hospital Principal Investigator (PI)︰Prof. Ping-I Hsu Research Project
Estonian Statistics on Medicines 2017 1/42
Top View
H. PYLORI ERADICATION OPTIONS for PEPTIC ULCER DISEASE Proton Pump Inhibitor-Based Treatments Other Combination Therapy H 2 Rece
The Influence of Pre-Treatment with a Proton Pump Inhibitor / H2 Receptor Antagonists on Helicobacter Pylori Eradication
Package Leaflet
Pharmaceutical Preparation for the Treatment of Gastritis, Reflux Oesophagitis, Duodenitis, Dyspepsia and Ulcer Disease
Role of Gastric Acid Suppression in the Treatment of Gastro-Oesophageal Reflux Disease
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First‐Line Treatment of Helicobacter Pylori Infection
Helicobacter Pylori
ACG 2010! the Premier GI Clinical Event of the Year!
Helicobacter Pylori the Latest in Diagnosis and Treatment
Drug Usage Patterns of Pylera® in France Using the National Claims Reimbursement Database
Effect of Helicobacter Pylori Infection on Colloidal
These Highlights Do Not Include All the Information Needed to Use PYLERA Safely and Effectively. See Full Prescribing Information for PYLERA
(EDL) and a Licensed Drugs List (LDL) for Afghanistan
Summary of Product Characteristics Or As Reported in the Literature
Adding Bismuth to Rabeprazole-Based First-Line Triple Therapy Does Not Improve the Eradication of Helicobacter Pylori
Atypical Antipsychotics
Drug Utilization Patterns Among Elderly Hospitalized Patients on Poly
Baltic Statistics on Medicines 2010–2012 2 | Sales Statistics 2010–2012 Sales Statistics 2010–2012 |
A Double Capsule for the Administration of Active Principles in Multiple Therapies
Bismuth Subsalicylate Reduces Peptic Injury Ofthe Oesophagus in Rabbits
ACG Clinical Guideline: Treatment of Helicobacter Pylori Infection
Pylera Ct 12234.Pdf
Resolution Ap (2000) 1
(12) United States Patent (10) Patent No.: US 6,350,468 B1 Sanso (45) Date of Patent: Feb
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Omeprazole Enhances Efficacy of Triple Therapyin Eradicating Helicobacter Pyloni